Negative effects of long-term exposure to particulate matter (PM) on lung function have been shown repeatedly. Spatial differences in the composition and toxicity of PM may explain differences in observed effect sizes between studies.
We conducted a multicenter study in 5 European birth cohorts—BAMSE (Sweden), GINIplus and LISAplus (Germany), MAAS (United Kingdom), and PIAMA (The Netherlands)—for which lung function measurements were available for study subjects at the age of 6 or 8 years. Individual annual average residential exposure to copper, iron, potassium, nickel, sulfur, silicon, vanadium, and zinc within PM smaller than 2.5 μm (PM2.5) and smaller than 10 μm (PM10) was estimated using land-use regression models. Associations between air pollution and lung function were analyzed by linear regression within cohorts, adjusting for potential confounders, and then combined by random effects meta-analysis.
We observed small reductions in forced expiratory volume in the first second, forced vital capacity, and peak expiratory flow related to exposure to most elemental pollutants, with the most substantial negative associations found for nickel and sulfur. PM10 nickel and PM10 sulfur were associated with decreases in forced expiratory volume in the first second of 1.6% (95% confidence interval = 0.4% to 2.7%) and 2.3% (−0.1% to 4.6%) per increase in exposure of 2 and 200 ng/m3, respectively. Associations remained after adjusting for PM mass. However, associations with these elements were not evident in all cohorts, and heterogeneity of associations with exposure to various components was larger than for exposure to PM mass.
Although we detected small adverse effects on lung function associated with annual average levels of some of the evaluated elements (particularly nickel and sulfur), lower lung function was more consistently associated with increased PM mass.
Supplemental Digital Content is available in the text.
From the aInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands; bDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland; cUniversity of Basel, Basel, Switzerland; dKarolinska Institute, Institute of Environmental Medicine, Stockholm, Sweden; eCentre for Occupational and Environmental Health, University of Manchester, Manchester, United Kingdom; fJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; gUniversity of Manchester, Manchester Academic Health Science Centre, Institute of Inflammation and Repair, University Hospital of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom; hHelmholtz Zentrum München, German Research Center for Environmental Health, Institute of Epidemiology II, Neuherberg, Germany; iUniversity of Augsburg, Environmental Science Center, Augsburg, Germany; jHelmholtz Zentrum München, German Research Center for Environmental Health, Institute of Epidemiology I, Neuherberg, Germany; kSchool of Population and Public Health, University of British Columbia, Vancouver, Canada; lIUF Leibniz Research Institute for Environmental Medicine, University of Düsseldorf, Düsseldorf, Germany; mMedical Faculty, Heinrich-Heine University of Düsseldorf, Düsseldorf, Germany; nMRC-HPA Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom; oTNO, Netherlands Organization for Applied Scientific Research, Utrecht, The Netherlands; pUniversity of Groningen, University Medical Center Groningen, GRIAC Research Institute and Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children’s Hospital, Groningen, The Netherlands; qAir Quality & Sustainable Nanotechnology, IUTA e.V., and CENIDE at the University of Duisburg-Essen, Duisburg, Germany; and rDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA.
Submitted 05 July 2013; accepted 14 March 2014.
The research leading to these results has received funding from the European Community’s Seventh Framework Program (FP7/2007-2011): ESCAPE (grant agreement number: 211250) and TRANSPHORM (ENV.2009.1.2.2.1). The BAMSE study is supported by the Swedish Research Council FORMAS, the Stockholm County Council, the Swedish Foundation for Health Care Sciences and Allergy Research, and the Swedish Environmental Protection Agency. The GINIplus and LISAplus studies were supported by the Federal Ministry for Education, Science, Research and Technology, Helmholtz Zentrum Munich, Marien-Hospital Wesel, LMU Munich, TU Munich, IUF - Leibniz Research Institute for Environmental Medicine, a grant from the Federal Ministry for Environment (IUF, FKZ 20462296), Helmholtz Centre for Environmental Research - UFZ in Leipzig and Pediatric Practice in Bad Honnef. MAAS was supported by Asthma UK Grant No. 04/014, JP Moulton Charitable Foundation, and MRC Grant G0601361. The PIAMA study is supported by the Netherlands Organization for Health Research and Development, the Netherlands Organization for Scientific Research, the Netherlands Asthma Fund, the Netherlands Ministry of Spatial Planning, Housing and the Environment, and the Netherlands Ministry of Health, Welfare, and Sport.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com). This content is not peer-reviewed or copy-edited; it is the sole responsibility of the authors.
Corresponding: Marloes Eeftens, Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland. E-mail: firstname.lastname@example.org.